Martin F. Sprinzl - Concepedia

Author

Martin F. Sprinzl

Johannes Gutenberg University Mainz ORCID

Also Known As

Arndt Weinmann, Bernd Claus, Ivanka Krznaric, M F Sprinzl, M SPRINZL, M Sprinzl, M. F. Sprinzl, M. Sprinzl, M.F. Sprinzl, Martin F Sprinzl

128

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Technical University of Munich Helmholtz Zentrum München Heidelberg University

About

Martin F. Sprinzl is an author at Johannes Gutenberg University Mainz specializing in medicine, hepatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	1.6K
2	Cell Biology	3	3	233
3	Health Sciences	1	1	80
4	Natural Sciences	1	1	149
5	Diabetes	1	1	13

Martin F. Sprinzl

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA Julie Lucifora, Yuchen Xia, Florian Reisinger, Science Hbv Core ProteinImmunologyHepatitis BPathologyMolecular Biology	2014	857
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells Martin F. Sprinzl, Florian Reisinger, Andreas S. Puschnik, Hepatology	2013	168
Transfer of Hepatitis B Virus Genome by Adenovirus Vectors into Cultured Cells and Mice: Crossing the Species Barrier Martin F. Sprinzl, Heike Oberwinkler, Heinz Schaller, Journal of Virology Viral ReplicationImmunologyHepatitis BMolecular BiologySpecies Barrier	2001	149
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients Christian Labenz, Justine Baron, Gerrit Toenges, Alimentary Pharmacology & Therapeutics	2018	93
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice C. Dargel, Michal Bassani‐Sternberg, Julia Hasreiter, Gastroenterology Signal TransductionKill Hepatoma CellsReceptor Tyrosine KinaseT-regulatory CellImmunology	2015	90
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B Florian van Bömmel, Kerstin Stein, R Heyne, Journal of Hepatology Multicenter Randomized-controlled TrialAutoimmune DiseaseHepatologyIde Analogue CessationViral Hepatitis	2023	84
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial Fabien Zoulim, Claire Fournier, François Habersetzer, Human Vaccines & Immunotherapeutics	2019	83
Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion Martin F. Sprinzl, Andreas S. Puschnik, Anna Melissa Schlitter, Journal of Hepatology InflammationInsulin SignalingMacrophage-induced GrowthLiver PhysiologyPathology	2014	80
Survival analysis of proposed <scp>BCLC</scp>‐B subgroups in hepatocellular carcinoma patients Arndt Weinmann, Sandra Koch, Martin F. Sprinzl, Liver International	2014	71
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation Martin F. Sprinzl, Arndt Weinmann, Nikola Lohse, Transplant International	2012	69

Page 1